Lynne Peeples

Medicine’s secret ingredient — it’s in the timing

Lynne Peeples, Lynne Peeples, 2018, Nature.

Class-sparing regimens for initial treatment of HIV-1 infection.

Lynne Peeples, Richard Haubrich, Susan Swindells, 2008, The New England journal of medicine.

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

Lynne Peeples, David Katzenstein, Victoria A Johnson, 2009, The New England journal of medicine.